441 related articles for article (PubMed ID: 26263504)
1. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.
Sun Z; Xu R; Li X; Ren W; Ou C; Wang Q; Zhang H; Zhang X; Ma J; Wang H; Li G
PLoS One; 2015; 10(8):e0135119. PubMed ID: 26263504
[TBL] [Abstract][Full Text] [Related]
2. Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis.
Zhang L; Song X; Li X; Wu C; Jiang J
Biomed Res Int; 2018; 2018():4039173. PubMed ID: 30539010
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of YAP1 on clinical outcomes in human cancers.
Wu Y; Hou Y; Xu P; Deng Y; Liu K; Wang M; Tian T; Dai C; Li N; Hao Q; Song D; Zhou LH; Dai Z
Aging (Albany NY); 2019 Oct; 11(19):8681-8700. PubMed ID: 31613226
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.
Zhu L; Ma G; Liu J; Deng Y; Wu Q; Chen W; Zhou Q
Medicine (Baltimore); 2019 Apr; 98(16):e15069. PubMed ID: 31008931
[TBL] [Abstract][Full Text] [Related]
5. Prognostic analysis of Yes-associated protein 1 in patients with colorectal cancer. A systematic review and meta-analysis.
Zhang H; Yin M; Hu Y; Jiang M; Lu M; Wu Y
Rev Esp Enferm Dig; 2024 Mar; 116(3):148-156. PubMed ID: 36177818
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma: A systematic review and meta-analysis.
Hong X; Wang G; Xu G; Shi W; Wang T; Rong Z; Mo C
Medicine (Baltimore); 2022 Jan; 101(3):e28507. PubMed ID: 35060503
[TBL] [Abstract][Full Text] [Related]
8. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
Xia Y; Wei X; Gong H; Ni Y
BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
[TBL] [Abstract][Full Text] [Related]
10. Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature.
Poma AM; Torregrossa L; Bruno R; Basolo F; Fontanini G
Sci Rep; 2018 Jul; 8(1):10623. PubMed ID: 30006603
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis.
Chen X; Liang R; Lai L; Chen K; Zhu X
Front Oncol; 2021; 11():697369. PubMed ID: 34490092
[TBL] [Abstract][Full Text] [Related]
12. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.
Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS
APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730
[TBL] [Abstract][Full Text] [Related]
13. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
[TBL] [Abstract][Full Text] [Related]
14. Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis.
Shan W; Sun C; Zhou B; Guo E; Lu H; Xia M; Li K; Weng D; Lin X; Meng L; Ma D; Chen G
Oncotarget; 2016 Nov; 7(45):72672-72684. PubMed ID: 27682871
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival.
Hong SA; Jang SH; Oh MH; Kim SJ; Kang JH; Hong SH
Pathol Res Pract; 2018 Mar; 214(3):335-342. PubMed ID: 29487002
[TBL] [Abstract][Full Text] [Related]
17. The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
Cha YJ; Kim D; Bae SJ; Ahn SG; Jeong J; Cho MK; Paik PS; Yoo TK; Park WC; Yoon CI
PLoS One; 2021; 16(5):e0250986. PubMed ID: 33970925
[TBL] [Abstract][Full Text] [Related]
18. The prognostic implication of slug in all tumour patients - a systematic meta-analysis.
Huang C; Zhang P; Zhang D; Weng X
Eur J Clin Invest; 2016 May; 46(5):398-407. PubMed ID: 26919035
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of TAZ expression in various cancers: a meta-analysis.
Feng J; Ren P; Gou J; Li Z
Onco Targets Ther; 2016; 9():5235-44. PubMed ID: 27601916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
